Literature DB >> 3592398

Comparison of clinical dyspnea ratings and psychophysical measurements of respiratory sensation in obstructive airway disease.

D A Mahler, R A Rosiello, A Harver, T Lentine, J F McGovern, J A Daubenspeck.   

Abstract

To investigate the hypothesis that clinical methods and psychophysical testing provide different information about breathlessness, we compared dyspnea ratings from a modified Medical Research Council (MRC) scale, the Oxygen-Cost Diagram (OCD), and the Baseline Dyspnea Index (BDI) with the perceived magnitude of added loads in 24 patients with obstructive airway disease (OAD) who experienced dyspnea on exertion. Age of the patients was 55.8 +/- 13.7 yr (mean +/- SD), FEV1 was 1.77 +/- 0.81 L, and FEV1/FVC ratio was 52.6 +/- 10.5%. Dyspnea ratings were obtained for each clinical method by 2 independent observers; estimates of the magnitude of 5 resistive loads (10 to 85 cm H2O/L/s) were obtained using the Borg category scale (0 to 10). For comparative purposes, 12 age-matched (48.9 +/- 13.5 yr) healthy subjects were also studied. Clinical ratings of dyspnea obtained in patients for MRC (range, 0 to 4), OCD (range, 23 to 98), and BDI (range, 0.5 to 12.0) were all highly interrelated (rs = 0.79, -0.83, and -0.71; p less than 0.001 for all comparisons). Exponents of the psychophysical power function for resistive breathing loads were similar for patients with OAD (0.57 +/- 0.27) and control subjects (0.63 +/- 0.18) (p = NS). Clinical dyspnea scores were significantly correlated with both FEV1 and FVC; however, neither dyspnea ratings nor lung function were significantly related to the exponent for added breathing loads in the patient group. These comparisons indicate that in patients with symptomatic OAD, clinical methods for rating dyspnea are interrelated and are correlated with lung function, but are independent of perception of resistive breathing loads.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1987        PMID: 3592398     DOI: 10.1164/arrd.1987.135.6.1229

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  29 in total

Review 1.  Quality of life instruments in the evaluation of new drugs.

Authors:  R Jaeschke; G H Guyatt; D Cook
Journal:  Pharmacoeconomics       Date:  1992-02       Impact factor: 4.981

2.  Grouping and multidimensional organization of respiratory sensations.

Authors:  A Harver; J C Baird; J F McGovern; J A Daubenspeck
Journal:  Percept Psychophys       Date:  1988-09

Review 3.  Pulmonary rehabilitation in chronic respiratory insufficiency. 7. Health-related quality of life among patients with chronic obstructive pulmonary disease.

Authors:  J R Curtis; R A Deyo; L D Hudson
Journal:  Thorax       Date:  1994-02       Impact factor: 9.139

4.  Sleep quality, depression, and quality of life in patients with pulmonary hypertension.

Authors:  Omar Batal; Omar F Khatib; Nancy Bair; Loutfi S Aboussouan; Omar A Minai
Journal:  Lung       Date:  2010-12-21       Impact factor: 2.584

Review 5.  End points for comparative effectiveness research in heart failure.

Authors:  Larry A Allen; John A Spertus
Journal:  Heart Fail Clin       Date:  2012-10-18       Impact factor: 3.179

6.  Lung volume reduction surgery and pulmonary rehabilitation improve exercise capacity and reduce dyspnea during functional activities in people with emphysema.

Authors:  Janna Beling
Journal:  Cardiopulm Phys Ther J       Date:  2009-06

Review 7.  Measurement of dyspnoea in chronic obstructive pulmonary disease.

Authors:  E G Eakin; R M Kaplan; A L Ries
Journal:  Qual Life Res       Date:  1993-06       Impact factor: 4.147

8.  MRC chronic Dyspnea Scale: Relationships with cardiopulmonary exercise testing and 6-minute walk test in idiopathic pulmonary fibrosis patients: a prospective study.

Authors:  Effrosyni D Manali; Panagiotis Lyberopoulos; Christina Triantafillidou; Likourgos F Kolilekas; Christina Sotiropoulou; Joseph Milic-Emili; Charis Roussos; Spyros A Papiris
Journal:  BMC Pulm Med       Date:  2010-05-28       Impact factor: 3.317

9.  Efficacy of inhaled salmeterol in the management of smokers with chronic obstructive pulmonary disease: a single centre randomised, double blind, placebo controlled, crossover study.

Authors:  C S Ulrik
Journal:  Thorax       Date:  1995-07       Impact factor: 9.139

10.  Clinical Impact of Intrapulmonary Vascular Dilatation in Candidates for Liver Transplant.

Authors:  Hilary M DuBrock; Michael J Krowka; Kimberly A Forde; Karen Krok; Mamta Patel; Tiffany Sharkoski; Michael Sprys; Grace Lin; Jae K Oh; Carl D Mottram; Paul D Scanlon; Michael B Fallon; Steven M Kawut
Journal:  Chest       Date:  2017-10-05       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.